Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 7Recurrence 2Prostatic Neoplasms 2Brain Neoplasms 2Astrocytoma 2Optic Nerve Glioma 1Oligodendroglioma 1Metatropic dwarfism 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Gliosarcoma 1Glioma 1Diffuse Intrinsic Pontine Glioma 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 7Radiotherapy 3Everolimus 3nimotuzumab 2Erlotinib Hydrochloride 2Cyclophosphamide 2Bevacizumab 2tovorafenib 1ribociclib 1palbociclib 1olutasidenib 1antineoplaston AS 2-1 1antineoplaston A10 1Vinorelbine 1Valproic Acid 1Topotecan 1TIC10 compound 1Radiation 1Proto-Oncogene Proteins c-akt 1Phosphatidylinositol 3-Kinases 1Panobinostat 1Lomustine 1Irinotecan 1Injections 1GDC-0084 1Etoposide 1Drug Therapy 1Doxorubicin 1Diphtheria-Tetanus Vaccine 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Diffuse Intrinsic Pontine Glioma × Cilengitide × Clear all
NCT01517776 2015-07-21

HGG-CilMetro

Martin-Luther-Universität Halle-Wittenberg

Phase 2 Terminated
28 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡